The single-use urinary catheter mucosal irritation test is a critical biocompatibility evaluation that assesses whether catheter materials or their extracts cause adverse irritation when in contact with mucous membranes of the urinary tract. Performed in accordance with ISO 10993-10 and GB/T 16886.10 standards, this test is a mandatory component of regulatory submissions for disposable urinary catheters in China, Europe, and North America. This article provides a comprehensive technical overview of sample preparation, test methodologies, scoring criteria, and practical applications of mucosal irritation testing for single-use catheters.
Technical Overview
Single-use urinary catheters are classified as surface-contacting medical devices that interact with mucosal membranes of the urethra and bladder. Because these devices remain in direct contact with fragile mucosal tissue for durations ranging from minutes to several weeks, any residual monomers, processing additives, sterilant byproducts, or extractable chemicals leaching from the catheter material may provoke local inflammatory responses such as erythema and edema. The mucosal irritation test is designed to quantitatively evaluate this hazard potential before clinical use.
The test is conducted in accordance with ISO 10993-10 (Biological evaluation of medical devices — Part 10: Tests for irritation and skin sensitization) and its Chinese equivalent GB/T 16886.10-2017. Sample preparation follows ISO 10993-12 and GB/T 16886.12. For regulatory purposes, mucosal irritation evaluation is required by NMPA in China, notified bodies under the EU MDR, and the FDA for 510(k) and PMA submissions, because irritation testing is explicitly listed in the ISO 10993-1 biological evaluation matrix for devices contacting mucosal membranes for limited (≤24 hours) or prolonged (24 hours to 30 days) contact durations.
The standard approach involves preparing polar and non-polar extracts of the finished sterile catheter, applying the extracts to the vaginal mucosa of healthy rabbits, and evaluating the tissue response through both macroscopic scoring and histopathological examination. The outcome directly supports the biological safety conclusion in the device's biocompatibility risk assessment file.
Testing Samples
Finished Product Samples
Testing should be performed on the final catheter product in its sterilized, ready-to-use condition, since sterilization methods such as ethylene oxide (EtO) or gamma irradiation can generate irritant residues or degradation products. Samples are typically supplied sterile in their primary packaging, and the sample description must document product model, lot number, material composition (e.g., natural latex, silicone, polyvinyl chloride, polyurethane), dimensions, and sterilization method.
Extract Preparation
Because the catheter is a tubular device with both external and internal luminal surfaces, the extraction is performed using the total contact surface area. Extraction media and ratio requirements include:
- Polar medium: 0.9% sodium chloride injection or water for injection, suitable for extracting water-soluble irritants.
- Non-polar medium: sesame oil or cottonseed oil, suitable for extracting lipophilic substances such as plasticizers and process oils.
- Extraction ratio: 6 cm²/mL for material thickness of 0.5 mm or less; 3 cm²/mL for thickness of 0.5–1.0 mm; 3 cm²/g for thickness greater than 1.0 mm, in accordance with ISO 10993-12.
- Extraction conditions: 37°C ± 1°C for 24 ± 2 hours, 50°C ± 2°C for 72 ± 2 hours, or 70°C ± 2°C for 24 ± 2 hours; the 37°C condition is preferred when it represents worst-case clinical exposure.
Control Materials
Each test requires corresponding controls to validate the study design. The negative control consists of the extraction vehicle incubated under identical conditions without the test article. Where method validation or benchmarking is required, a positive control irritant such as a diluted detergent solution may be included periodically by the testing laboratory to demonstrate test sensitivity.
Testing Items
The mucosal irritation test evaluates both macroscopic and microscopic tissue responses. The primary test items include:
- Macroscopic irritation response: erythema and eschar formation at the application site, scored on a 0–4 numerical scale.
- Edema formation: swelling of the mucosal tissue, scored on a 0–4 numerical scale.
- Histopathological examination: microscopic evaluation of mucosal tissue sections for epithelial integrity loss, epithelial hyperplasia or degeneration, submucosal edema, leukocyte infiltration, and vascular congestion.
- Systemic observations: animal body weight, general health status, and any adverse clinical signs recorded throughout the study.
- Extraction medium verification: confirmation of extract appearance, pH, and sterility to rule out artifacts caused by microbial contamination.
Testing Methods
In Vivo Vaginal Irritation Test
The rabbit vaginal mucosa model is the internationally recognized reference method for assessing mucosal irritation because the tissue structure and response profile closely resemble human urothelial and mucosal reactivity. The procedure is as follows:
- Animal selection: healthy, adult, nulliparous female New Zealand white rabbits, typically three to six animals per group (test extract and control), acclimated for at least 5–7 days before dosing.
- Dose administration: 1 mL of the test extract is gently instilled into the vaginal cavity using a soft applicator or catheter tip; the control group receives the corresponding blank extraction medium.
- Exposure regimen: for devices with short-term mucosal contact, a single exposure with observation at 1, 24, 48, and 72 hours is applied; for devices intended for repeated or prolonged contact, exposure is repeated once daily for up to five consecutive days.
- Post-exposure observation: the vaginal mucosa is visually examined and scored for erythema and edema at each designated observation time point by trained personnel blinded to the treatment allocation where feasible.
- Termination and necropsy: at the final observation, animals are humanely euthanized, and vaginal tissues are excised, fixed in formalin, embedded, sectioned, and stained with hematoxylin-eosin for histopathological assessment.
Scoring System
Macroscopic scoring follows the numerical scale defined in ISO 10993-10: a score of 0 indicates no reaction, 1 very slight erythema or edema, 2 well-defined reaction, 3 moderate reaction, and 4 severe reaction. The microscopic scoring system evaluates four parameters—epithelial changes, leukocyte infiltration, vascular congestion, and edema—each graded from 0 (normal) to 4 (severe involvement), yielding a total histological score per animal.
Result Interpretation
The irritation response is determined by calculating the difference between the mean test-article score and the mean control score for both macroscopic and histopathological endpoints. The test sample is considered non-irritant to mucous membranes when the test group response does not exceed the control group response, and no statistically significant difference is detected in the histopathological comparison. A positive reaction, such as a mean score difference greater than 1 accompanied by consistent histological lesions, indicates irritant potential and triggers a material review or risk mitigation strategy.
In Vitro Alternative Methods
To support the 3Rs principle (replacement, reduction, refinement), reconstructed human vaginal epithelium models such as EpiVaginal tissue constructs may be used as screening tools, measuring tissue viability (MTT assay) and inflammatory mediator release (IL-1α, IL-6, IL-8) after extract exposure. These methods are increasingly accepted as supplementary evidence, particularly for material changes or batch screening, although regulatory authorities in most jurisdictions still expect confirmatory in vivo data for new device registrations unless a validated alternative is justified in the biological evaluation plan.
Applications
The mucosal irritation test for single-use urinary catheters serves multiple purposes across the product lifecycle:
- Registration submissions: providing the irritation endpoint required in biological evaluation reports for NMPA registration dossiers in China, CE technical documentation under EU MDR, and FDA 510(k) submissions in the United States.
- New product development: comparing the mucosal safety of candidate materials such as silicone, PVC, polyurethane, and hydrogel-coated latex before final material selection.
- Change control: re-evaluating biocompatibility following changes in raw material supplier, formulation, manufacturing process, or sterilization method.
- Packaging and shelf-life studies: supporting the biological safety of aged products at the end of validated shelf life.
- Litigation and complaint investigation: providing objective evidence when clinical adverse events involving urethral discomfort, burning, or inflammation are reported.
- Ethylene oxide residual assessment complement: verifying that sterilization residues and degradation products do not produce local mucosal reactions at clinically relevant extract concentrations.
FAQ
What standards govern the single-use urinary catheter mucosal irritation test?
The test is primarily governed by ISO 10993-10:2021 and GB/T 16886.10-2017, with sample preparation conducted per ISO 10993-12 and GB/T 16886.12. In China, product-specific requirements may also reference YY/T standards applicable to sterile single-use urethral catheters.
How many test animals and how much sample are required?
A typical study uses three rabbits per group for both polar and non-polar extract evaluations. Sample quantity depends on the surface-area-to-volume extraction ratio; for a standard 16 Fr catheter, complete devices or representative sections totaling the required contact area are generally sufficient. Testing laboratories can calculate exact sample needs from product drawings.
What is the typical test duration?
Including quarantine and acclimatization, extract preparation, a five-day exposure period, observation, and histopathological processing, the complete study usually requires three to five weeks, with histopathology often being the critical-path activity.
What result constitutes a pass?
A passing result is achieved when the macroscopic and histopathological reactions of the test extract group are not greater than those of the corresponding control group, with no statistically significant differences, indicating the catheter extract is non-irritant to mucous membranes.
Can in vitro tests replace the rabbit vaginal irritation test?
Reconstructed tissue models such as EpiVaginal are valuable screening tools and are increasingly used to reduce animal use. However, most regulatory bodies, including NMPA, currently expect in vivo mucosal irritation data for new catheter registrations unless a scientifically justified alternative strategy is documented in the biological evaluation report.